Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Biopharmaceutical company fined for misleading investors

      Biopharmaceutical company fined for misleading investors

      Medical Dialogues Bureau20 Sept 2018 1:48 PM IST
      BOULDER, Colo. - A Colorado-based biopharmaceutical company has been penalized more than $20 million for misleading investors about the efficacy of a...
      Bayer Monsan to asks U.S. court to toss $289 mln glyphosate verdict

      Bayer Monsan to asks U.S. court to toss $289 mln glyphosate verdict

      Medical Dialogues Bureau20 Sept 2018 1:47 PM IST
      US- Bayer AG unit Monsanto asked a California judge to throw out a $289 million jury verdict awarded to a man who alleged the company's...
      FDC Ban: Avoid These Combinations of Paracetamol

      FDC Ban: Avoid These Combinations of Paracetamol

      Medical Dialogues Bureau20 Sept 2018 12:39 PM IST
      New Delhi: The Government of India recently prohibited the manufacture for sale, sale and distribution for human use, 328 fixed-dose combinations,...
      GSK grabs new drug development head from Boehringer

      GSK grabs new drug development head from Boehringer

      Medical Dialogues Bureau20 Sept 2018 9:46 AM IST
      LONDON: GlaxoSmithKline has hired Chris Corsico from German drugmaker Boehringer Ingelheim to fill the new role of senior vice-president development...
      Glenmark Pharma finds way into Dow Jones Sustainability Indices

      Glenmark Pharma finds way into Dow Jones Sustainability Indices

      Medical Dialogues Bureau19 Sept 2018 4:02 PM IST
      Glenmark Pharmaceuticals inducted into the Dow Jones Sustainability Indices (DJSI) Emerging Market 2018, one of the most prestigious global...
      Sun Pharma Gets European approval for Ilumetri to treat Psoiasis

      Sun Pharma Gets European approval for Ilumetri to treat Psoiasis

      Medical Dialogues Bureau19 Sept 2018 4:00 PM IST
      Mumbai: Sun Pharma has recently announced that Almirall has received the European Commission (EC) approval for the treatment of adults with...
      No coercive steps to be taken against drug firms for FDCs already in market: Delhi HC

      No coercive steps to be taken against drug firms for FDCs already in market: Delhi HC

      Medical Dialogues Bureau19 Sept 2018 11:41 AM IST
      No coercive steps are taken against FDC drug Indian pharma major Wockhardt for sale of stock, already in the market, of its anti-inflammatory medicine...
      Ugandan unit of Cipla raises $43.8 mln in IPO - Renaissance Capital

      Ugandan unit of Cipla raises $43.8 mln in IPO - Renaissance Capital

      Medical Dialogues Bureau19 Sept 2018 11:40 AM IST
      Cipla Quality Chemical Industries Ltd (CQCIL), majority owned by India's third-largest drugmaker, sold 657 million shares equivalent to 18 per cent of...
      Strides Pharma gets 3 observations from USFDA for Bangalore plant

      Strides Pharma gets 3 observations from USFDA for Bangalore plant

      Medical Dialogues Bureau19 Sept 2018 9:36 AM IST
      The company believes that the observations are not material in nature and have already responded to the USFDA, it added.New Delhi: Drug firm Strides...
      Aurobindo Pharma gets nod for for fixed dose triple combination for HIV

      Aurobindo Pharma gets nod for for fixed dose triple combination for HIV

      Medical Dialogues Bureau18 Sept 2018 2:34 PM IST
      Aurobindo Pharma has received approval from SAHPRA and tentative approval from USFDA for the Dolutegravir, Lamivudine and Tenofovir Disoproxil...
      Policybazaar Group injects Rs 362 Crore in docprime.com

      Policybazaar Group injects Rs 362 Crore in docprime.com

      Medical Dialogues Bureau18 Sept 2018 1:49 PM IST
      DocPrime is a new venture by the PolicyBazaar Group that owns India's leading insurance brand PolicyBazaar.com and top fintech marketplace...
      FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

      FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

      Medical Dialogues Bureau18 Sept 2018 12:47 PM IST
      Supreme court lifted the ban on the sale of Piramal Healthcare's Saridon, GlaxoSmithKline's Piriton, Juggat Pharma's Dart and another drug, banned...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok